Abstract:In 2020, cancer-related deaths reached 9.96 million globally, of which China accounted for 3 million, ranking first in the world. Phosphoglycerate mutase 1 (PGAM1) is a key metabolic enzyme in glycolysis, catalysing the conversion of 3-phosphoglycerate to 2-phosphoglycerate. Based on the excellent anticancer activity of PGMI-004A and HKB99, new small molecules with an anthraquinone core were synthesised to inhibit tumour growth. Developing small molecules with an anthraquinone core targeting PGAM1 may be an effective strategy for treating cancer. In this study, accelerated molecular dynamics (aMD) simulation, dynamic cross-correlation map (DCCM) calculation, principal component analysis (PCA) and free energy landscape (FEL) analysis were used to analyse conformational changes of PGAM1 caused by binding of inhibitors 8KX, 9HU and HKB. DCCM calculation and PCA showed that inhibitor binding significantly affected the kinetic behaviour of PGAM1 and conformational rearrangement of PGAM1. The binding ability and mechanism of 8KX, 9HU and HKB to PGAM1 were studied using the molecular mechanics generalised Born surface area (MM-GBSA) method. The results showed that compared with 8KX, the binding ability of 9HU and HKB to PGAM1 was enhanced by sulphonamide reversal and aminocarboxyl trifluoromethyl substitution. There were several hydrophobic interactions between inhibitors and PGAM1, providing significant contributions for inhibitor binding. Calculation of residue-based free energy decomposition, revealed that F22, R90, Y92, L95, V112, W115, R116, V121, P123, P124, R191 and M206 were key residues of the PGAM1–inhibitor interaction, and could be used as effective targets for designing drugs that inhibit the activity of PGAM1.

Research Progress of Phosphoglycerate Mutase

Conformation and Dynamics of the C-terminal Region in Human Phosphoglycerate Mutase 1

Effects of glucose-1-phosphate on the biosynthesis ofGanoderma lucidum polysaccharide

Phosphoenolpyruvate Carboxykinase in Cell Metabolism: Roles and Mechanisms Beyond Gluconeogenesis.

Crystal structure of human B-type phosphoglycerate mutase bound with citrate.

Structural and Functional Insights Into CmGH1, a Novel GH39 Family β-Glucosidase From Deep-Sea Bacterium.

Cloning, Purification, Crystallization and Preliminary Crystallographic Analysis of Human Phosphoglycerate Mutase.

Role of phosphoglycerate mutase 1 in the occurence and development of tumor

Cloning, Expression, and Characterization of a Phosphoglucomutase from Paenibacillus mucilaginosus

Mutations in hereditary phosphoglucomutase 1 deficiency map to key regions of enzyme structure and function

Unraveling the Mechanism: How Does Β-Phosphoglucomutase from the Haloacid Dehalogenase Superfamily Catalyze the Interconversion of Β-D-glucose 1-Phosphate and Β-D-glucose 6-Phosphate? A Chemical Perspective

Research Progress of Glucose Phosphate Isomerase

Crystal Structure of Human Bisphosphoglycerate Mutase

Clinical and Molecular Genetic Characterization of Two Patients with Mutations in the Phosphoglucomutase 1 (PGM1) Gene

Synthesis and Biological Evaluation of Anthraquinone Derivatives As Allosteric Phosphoglycerate Mutase 1 Inhibitors for Cancer Treatment.

Design, Synthesis, and Biological Evaluation of 1,3,6,7-Tetrahydroxyxanthone Derivatives As Phosphoglycerate Mutase 1 Inhibitors

Accelerated molecular dynamics study of interaction mechanism between small molecule inhibitors and phosphoglycerate mutantase 1

The Design and Synthesis of N-Xanthone Benzenesulfonamides As Novel Phosphoglycerate Mutase 1 (PGAM1) Inhibitors

Novel Structures of Type 1 Glyceraldehyde-3-phosphate Dehydrogenase from Escherichia Coli Provide New Insights into the Mechanism of Generation of 1,3-Bisphosphoglyceric Acid.

Seeing the Process of Histidine Phosphorylation in Human Bisphosphoglycerate Mutase

Molecular modeling and molecular dynamics simulation studies of the GSK3β/ATP/substrate complex: understanding the unique P+4 primed phosphorylation specificity for GSK3β substrates.